AMGEN INC (AMGN)       244  +0.15 (+0.06%)

244  +0.15 (+0.06%)

US0311621009 - Common Stock - After market: 244.7 +0.7 (+0.29%)

AMGEN INC244

NASDAQ:AMGN (2/7/2023, 7:23:44 PM)+0.15 (+0.06%)

After market: 244.7 +0.7 (+0.29%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 01-31 2023-01-31/amc Earnings (Next) 04-25 2023-04-25/amc
Ins Owners 0.19% Inst Owners 76.96%
Market Cap 130.19B Shares 533.58M
PE 20.15 Fwd PE 12.89
Dividend Yield 3.48% Analysts 68.48
IPO 06-17 1983-06-17

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AMGN Daily chart

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. The company is headquartered in Thousand Oaks, California and currently employs 24,200 full-time employees. The firm discovers, develops, manufactures and delivers various human therapeutics. The company operates in human therapeutics segment. Its marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq), Evenity, LumaKras, Nplate, XGeva, and others. The firm focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.

Company Info

AMGEN INC

One Amgen Center Drive

Thousand Oaks CALIFORNIA 91320

P: 18054471000.0

CEO: Robert A. Bradway

Employees: 24200

Website: https://www.amgen.com/

AMGN News

News Imagea day ago - Market News VideoCaterpillar Takes Over #61 Spot From AmgenNews Image2 days ago - Seeking AlphaTeva follows AbbVie to leave top pharma industry group (NYSE:TEVA)

Teva Pharmaceutical (TEVA) is the latest drugmaker to leave the influential industry trade group PhRMA following a similar move AbbVie (ABBV) late last year. Read the full story here.

News Image4 days ago - The Motley FoolWill These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?

Bristol Myers Squibb has solid replacements for its blockbusters that are facing a patent cliff.

News Image5 days ago - Investor's Business DailyMarket Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review

The major indexes continued to run despite mixed-to-weak earnings.

News Image6 days ago - InvestorPlaceThe 7 Most Undervalued Dow Stocks to Buy in February 2023

If you’re looking for the best deals among the most iconic enterprises, these are the most undervalued Dow stocks to buy.

News Image6 days ago - Market News VideoNotable Thursday Option Activity: AMGN, GM, CCL

AMGN Twits

Here you can normally see the latest stock twits on AMGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example